DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions
Drug Master Files, or DMFs, are confidential documents that play a crucial role in the pharmaceutica
FDA’s June 2024 list of off-patent, off-exclusivity drugs sees rise in cancer, HIV treatments
This week PharmaCompass brings to you key highlights of the US Food and Drug Administration’s
Top drugs and pharmaceutical companies of 2019 by revenues
Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-
Top drugs by sales in 2017: Who sold the blockbuster drugs?
The year 2017 was a landmark year for pharmaceutical
industries in the US and Europe, with a sharp i
Pfizer sues J&J; Generics under pressure; China’s Fosun resurrects deal to buyout India’s Gland
This week, Phispers brings you news on how a federal judge in the US revoked ‘pharma bro&rsquo
Dr. Reddy’s fails EU inspection; Trump disbands business councils after Merck CEO and others quit it over intolerance
This week, Phispers brings you the high-pitched drama from President Trump’s American Manufact
FDA reorganizes inspection staff; Thermo Fisher buys Patheon for $ 5.2 billion
This week in Phispers, read about the extortion cyberattack and how it impacted hospitals in the UK.
Sanofi lawsuit highlights Mylan’s unfair trade practices; Fresenius goes on multi-billion dollar spending spree
This week, Phispers brings you an update on M&As in the drug and medical equipment industry, alo
Drug costs and prescription trends in the United States: Analyzing Medicare’s $121 billion spend
In less than three weeks, Donald Trump will assume office as the
President of the United States. He